Ads
related to: nice guidelines on adrenal insufficiency disorder in adults with diabetes- Clinical Studies
See efficacy results from two
clinical studies. Review the data.
- Dosing and Monitoring
See optimal dosing and
monitoring guidance.
- Safety Profile
See safety and tolerability
profile. Review the data.
- Support for HCPs
Get support for your patients and
your practice. Sign up today.
- Clinical Studies
consumereview.org has been visited by 100K+ users in the past month
Search results
Results From The WOW.Com Content Network
Diabetes insipidus (DI) is a condition characterized by large amounts of dilute urine and increased thirst. [1] The amount of urine produced can be nearly 20 liters per day. [ 1 ] Reduction of fluid has little effect on the concentration of the urine. [ 1 ]
When used for assessing the integrity of the hypothalamic–pituitary–adrenal axis (HPA), insulin injections are continued to the point of inducing extreme hypoglycemia below 2.2 mmol/L (40 mg/dL). Patient must have symptomatic neuroglycopenia to trigger counter-regulatory cascade.
Adrenal crisis is a serious, life-threatening complication of adrenal insufficiency. Hypotension , or hypovolemic shock , is the main symptom of adrenal crisis, other indications and symptoms include weakness , anorexia , nausea , vomiting, fever, fatigue , abnormal electrolytes , confusion , and coma. [ 19 ]
Adrenal insufficiency can also result when a patient has a brain mass in the pituitary gland (e.g. pituitary adenoma, craniopharyngioma) which can take up space and interfere with the secretion of pituitary hormones such as ACTH, therefore leading to decreased adrenal stimulation (secondary adrenal insufficiency). [2]
Central diabetes insipidus is typically an acquired disorder. [9] The following conditions may result in central diabetes insipidus: [10] Surgery - Neurosurgery, typically in the sellar or suprasellar area, can induce central diabetes insipidus. [11] In most neurosurgery-related situations, central diabetes insipidus is temporary. [12]
PAS II is defined as the association between autoimmune Addison's disease and either autoimmune thyroid disease, type 1 diabetes, or both. [5] It is heterogeneous and has not been linked to one gene. Rather, individuals are at a higher risk when they carry a particular human leukocyte antigen (HLA-DQ2, HLA-DQ8 and HLA-DR4). APS-II affects women ...
Ad
related to: nice guidelines on adrenal insufficiency disorder in adults with diabetes